Literature DB >> 23824418

Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range.

Peter N Taylor1, Salman Razvi, Simon H Pearce, Colin M Dayan.   

Abstract

CONTEXT: Overt thyroid disease is associated with profound adverse health outcomes; however, data are conflicting for studies of borderline/subclinical thyroid dysfunction. Many studies of subclinical thyroid disease have had low power and were prone to selection bias. In contrast, large datasets are available from community studies in healthy individuals. Studies of the effects of variation of thyroid function across the reference range on health outcomes in these populations may provide useful information regarding thresholds for treatment of abnormal thyroid function. EVIDENCE ACQUISITION: MEDLINE and the Cochrane Database of Systematic Reviews and Controlled Trials Register were searched for articles studying the effect of variation in thyroid hormone parameters within the reference range on cardiovascular, bone, metabolic, pregnancy, neurological, and psychological outcomes. EVIDENCE SYNTHESIS: Higher TSH/lower thyroid hormone levels are associated with more cardiovascular risk factors and cardiovascular events and worse metabolic parameters and pregnancy outcomes, whereas lower TSH/higher thyroid hormone levels are associated with reduced bone mineral density and increased fracture risk. The evidence base was good for cardiovascular, metabolic, bone, and pregnancy outcomes; however, high-quality data remained lacking for neurological and psychological outcomes.
CONCLUSIONS: Common variation in persons with thyroid function in the normal range are associated with adverse health outcomes. These data suggest, by extrapolation, that carefully monitored treatment of even modest elevations of TSH may have substantial health benefits. Appropriately powered large-scale clinical trials analyzing the risks vs benefits of treating subclinical thyroid disease are required to determine whether these benefits can be achieved with levothyroxine therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824418     DOI: 10.1210/jc.2013-1315

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  85 in total

1.  Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.

Authors:  Jennifer S Mammen; John McGready; Rachael Oxman; Chee W Chia; Paul W Ladenson; Eleanor M Simonsick
Journal:  Thyroid       Date:  2015-08-13       Impact factor: 6.568

2.  Letter to: "Vitamin D levels and bone mass in rheumatoid arthritis".

Authors:  Bunyamin Koc; Hakan Sarman; Ismail Boyraz
Journal:  Rheumatol Int       Date:  2015-01-10       Impact factor: 2.631

3.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

4.  The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good.

Authors:  David J Stott; Douglas C Bauer; Ian Ford; Patricia Kearney; Jacobijn Gussekloo; Terence J Quinn; Nicolas Rodondi; Jan Smit; Rudi Westerdorp
Journal:  Eur Thyroid J       Date:  2014-06-11

5.  Guidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress?

Authors:  Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2015-08-21

6.  Thyroid Function Variations Within the Reference Range Do Not Affect Quality of Life, Mood, or Cognitive Function in Community-Dwelling Older Men.

Authors:  Mary H Samuels; Rajani Kaimal; Avantika Waring; Howard A Fink; Kristine Yaffe; Andrew R Hoffman; Eric Orwoll; Douglas Bauer
Journal:  Thyroid       Date:  2016-09       Impact factor: 6.568

7.  The hidden phenomenon of oxidative stress during treatment of subclinical-mild hypothyroidism: a protective nutraceutical intervention.

Authors:  Claudio Tomella; Roberto Catanzaro; Nicola Illuzzi; Anna Cabeca; Nicola Zerbinati; Gulcin Celep; Michele Milazzo; Chiara Sapienza; Angelo Italia; Aldo Lorenzetti; Francesco Marotta
Journal:  Rejuvenation Res       Date:  2014-04-08       Impact factor: 4.663

8.  Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.

Authors:  Angela R Buckalew; Jun Wang; Ashley S Murr; Chad Deisenroth; Wendy M Stewart; Tammy E Stoker; Susan C Laws
Journal:  Arch Toxicol       Date:  2020-02-17       Impact factor: 5.153

9.  Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States.

Authors:  Donghee Kim; Eric R Yoo; Andrew A Li; Christopher T Fernandes; Sean P Tighe; George Cholankeril; Bilal Hameed; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-17       Impact factor: 11.382

10.  Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis.

Authors:  Layal Chaker; Christine Baumgartner; Wendy P J den Elzen; Tinh-Hai Collet; M Arfan Ikram; Manuel R Blum; Abbas Dehghan; Christiane Drechsler; Robert N Luben; Marileen L P Portegies; Giorgio Iervasi; Marco Medici; David J Stott; Robin P Dullaart; Ian Ford; Alexandra Bremner; Anne B Newman; Christoph Wanner; José A Sgarbi; Marcus Dörr; W T Longstreth; Bruce M Psaty; Luigi Ferrucci; Rui M B Maciel; Rudi G Westendorp; J Wouter Jukema; Graziano Ceresini; Misa Imaizumi; Albert Hofman; Stephan J L Bakker; Jayne A Franklyn; Kay-Tee Khaw; Douglas C Bauer; John P Walsh; Salman Razvi; Jacobijn Gussekloo; Henry Völzke; Oscar H Franco; Anne R Cappola; Nicolas Rodondi; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.